FSTL1 and triple-A syndrome: Brown remodeling of white adipose tissue inhibited abdominal aortic aneurysm (AAA) progression via a vessel-protective adipokine Follistatin-like 1 (FSTL1), suggesting a novel therapeutic strategy for AAA intervention.